Proprotein convertase subtilisin/kexin type 9 potentially influences cholesterol uptake in macrophages and reverse cholesterol transport
出版年份 2013 全文链接
标题
Proprotein convertase subtilisin/kexin type 9 potentially influences cholesterol uptake in macrophages and reverse cholesterol transport
作者
关键词
-
出版物
FEBS LETTERS
Volume 587, Issue 9, Pages 1271-1274
出版商
Wiley
发表日期
2013-02-25
DOI
10.1016/j.febslet.2013.02.027
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Gene Inactivation of Proprotein Convertase Subtilisin/Kexin Type 9 Reduces Atherosclerosis in Mice
- (2012) Maxime Denis et al. CIRCULATION
- Safety and Efficacy of a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease, SAR236553/REGN727, in Patients With Primary Hypercholesterolemia Receiving Ongoing Stable Atorvastatin Therapy
- (2012) James M. McKenney et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol
- (2012) Evan A. Stein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical aspects of PCSK9
- (2011) Bertrand Cariou et al. ATHEROSCLEROSIS
- Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels
- (2011) Nicola Ferri et al. ATHEROSCLEROSIS
- PCSK9 siRNA inhibits HUVEC apoptosis induced by ox-LDL via Bcl/Bax–caspase9–caspase3 pathway
- (2011) Chun-Yan Wu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Cytokines, macrophage lipid metabolism and foam cells: Implications for cardiovascular disease therapy
- (2011) James E. McLaren et al. PROGRESS IN LIPID RESEARCH
- The ABC transporters in lipid flux and atherosclerosis
- (2011) Iryna Voloshyna et al. PROGRESS IN LIPID RESEARCH
- Increased Secretion of Lipoproteins in Transgenic Mice Expressing Human D374Y PCSK9 Under Physiological Genetic Control
- (2010) Bronwen Herbert et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Mechanisms of LDL oxidation
- (2010) Hiroshi Yoshida et al. CLINICA CHIMICA ACTA
- Future Therapeutic Directions in Reverse Cholesterol Transport
- (2010) Amit V. Khera et al. Current Atherosclerosis Reports
- Effects of pcsk9 siRNA on THP-1 Derived Macrophages Apoptosis Induced by oxLDL*
- (2010) Lu-Shan LIU et al. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS
- Proprotein Convertase Subtilisin Kexin Type 9 Null Mice Are Protected From Postprandial Triglyceridemia
- (2009) Cédric Le May et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The LDL Receptor
- (2009) Joseph L. Goldstein et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Secreted proprotein convertase subtilisin/kexin type 9 reduces both hepatic and extrahepatic low-density lipoprotein receptors in vivo
- (2008) Robert J. Schmidt et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- HDL, ABC Transporters, and Cholesterol Efflux: Implications for the Treatment of Atherosclerosis
- (2008) Alan R. Tall et al. Cell Metabolism
- PCSK9 as a therapeutic target of dyslipidemia
- (2008) Nabil G Seidah EXPERT OPINION ON THERAPEUTIC TARGETS
- Beyond High-Density Lipoprotein Cholesterol Levels
- (2008) Emil M. deGoma et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Inhibition of squalene synthase upregulates PCSK9 expression in rat liver
- (2007) Mohini Bedi et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started